Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Systematic analysis of Type I-E Escherichia coli CRISPR-Cas PAM sequences ability to promote interference and primed adaptation.

Musharova O, Sitnik V, Vlot M, Savitskaya E, Datsenko KA, Krivoy A, Fedorov I, Semenova E, Brouns SJJ, Severinov K.

Mol Microbiol. 2019 Jun;111(6):1558-1570. doi: 10.1111/mmi.14237. Epub 2019 Apr 6.

PMID:
30875129
2.

High-level, constitutive expression of the mgtC gene confers increased thermotolerance on Salmonella enterica serovar Typhimurium.

Gall AR, Hegarty AE, Datsenko KA, Westerman RP, SanMiguel P, Csonka LN.

Mol Microbiol. 2018 Aug;109(3):327-344. doi: 10.1111/mmi.13988. Epub 2018 Jul 31.

PMID:
29802740
3.

Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.

Musharova O, Klimuk E, Datsenko KA, Metlitskaya A, Logacheva M, Semenova E, Severinov K, Savitskaya E.

Nucleic Acids Res. 2017 Apr 7;45(6):3297-3307. doi: 10.1093/nar/gkx097.

4.

The action of Escherichia coli CRISPR-Cas system on lytic bacteriophages with different lifestyles and development strategies.

Strotskaya A, Savitskaya E, Metlitskaya A, Morozova N, Datsenko KA, Semenova E, Severinov K.

Nucleic Acids Res. 2017 Feb 28;45(4):1946-1957. doi: 10.1093/nar/gkx042.

5.

Mg2+ regulates transcription of mgtA in Salmonella Typhimurium via translation of proline codons during synthesis of the MgtL peptide.

Gall AR, Datsenko KA, Figueroa-Bossi N, Bossi L, Masuda I, Hou YM, Csonka LN.

Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):15096-15101. doi: 10.1073/pnas.1612268113. Epub 2016 Nov 14.

6.

Altered stoichiometry Escherichia coli Cascade complexes with shortened CRISPR RNA spacers are capable of interference and primed adaptation.

Kuznedelov K, Mekler V, Lemak S, Tokmina-Lukaszewska M, Datsenko KA, Jain I, Savitskaya E, Mallon J, Shmakov S, Bothner B, Bailey S, Yakunin AF, Severinov K, Semenova E.

Nucleic Acids Res. 2016 Dec 15;44(22):10849-10861. Epub 2016 Oct 13.

7.

Highly efficient primed spacer acquisition from targets destroyed by the Escherichia coli type I-E CRISPR-Cas interfering complex.

Semenova E, Savitskaya E, Musharova O, Strotskaya A, Vorontsova D, Datsenko KA, Logacheva MD, Severinov K.

Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7626-31. doi: 10.1073/pnas.1602639113. Epub 2016 Jun 20.

8.

Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.

Vorontsova D, Datsenko KA, Medvedeva S, Bondy-Denomy J, Savitskaya EE, Pougach K, Logacheva M, Wiedenheft B, Davidson AR, Severinov K, Semenova E.

Nucleic Acids Res. 2015 Dec 15;43(22):10848-60. doi: 10.1093/nar/gkv1261. Epub 2015 Nov 19.

9.

Erratum for Boudry et al., function of the CRISPR-Cas system of the human pathogen Clostridium difficile.

Boudry P, Semenova E, Monot M, Datsenko KA, Lopatina A, Sekulovic O, Ospina-Bedoya M, Fortier LC, Severinov K, Dupuy B, Soutourina O.

MBio. 2015 Oct 6;6(5):e01508-15. doi: 10.1128/mBio.01508-15. No abstract available.

10.

Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile.

Boudry P, Semenova E, Monot M, Datsenko KA, Lopatina A, Sekulovic O, Ospina-Bedoya M, Fortier LC, Severinov K, Dupuy B, Soutourina O.

MBio. 2015 Sep 1;6(5):e01112-15. doi: 10.1128/mBio.01112-15. Erratum in: MBio. 2015;6(5):e01508-15.

11.

The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system.

Semenova E, Kuznedelov K, Datsenko KA, Boudry PM, Savitskaya EE, Medvedeva S, Beloglazova N, Logacheva M, Yakunin AF, Severinov K.

Nucleic Acids Res. 2015 Jul 13;43(12):6049-61. doi: 10.1093/nar/gkv546. Epub 2015 May 26.

12.

CRISPR RNA binding and DNA target recognition by purified Cascade complexes from Escherichia coli.

Beloglazova N, Kuznedelov K, Flick R, Datsenko KA, Brown G, Popovic A, Lemak S, Semenova E, Severinov K, Yakunin AF.

Nucleic Acids Res. 2015 Jan;43(1):530-43. doi: 10.1093/nar/gku1285. Epub 2014 Dec 8.

13.

The RimL transacetylase provides resistance to translation inhibitor microcin C.

Kazakov T, Kuznedelov K, Semenova E, Mukhamedyarov D, Datsenko KA, Metlitskaya A, Vondenhoff GH, Tikhonov A, Agarwal V, Nair S, Van Aerschot A, Severinov K.

J Bacteriol. 2014 Oct;196(19):3377-85. doi: 10.1128/JB.01584-14. Epub 2014 Jul 7.

14.

Enzymatic synthesis of bioinformatically predicted microcin C-like compounds encoded by diverse bacteria.

Bantysh O, Serebryakova M, Makarova KS, Dubiley S, Datsenko KA, Severinov K.

MBio. 2014 May 6;5(3):e01059-14. doi: 10.1128/mBio.01059-14.

15.

Pervasive generation of oppositely oriented spacers during CRISPR adaptation.

Shmakov S, Savitskaya E, Semenova E, Logacheva MD, Datsenko KA, Severinov K.

Nucleic Acids Res. 2014 May;42(9):5907-16. doi: 10.1093/nar/gku226. Epub 2014 Apr 11.

16.

Development of a system for discovery of genetic interactions for essential genes in Escherichia coli K-12.

Yong HT, Yamamoto N, Takeuchi R, Hsieh YJ, Conrad TM, Datsenko KA, Nakayashiki T, Wanner BL, Mori H.

Genes Genet Syst. 2013;88(4):233-40.

17.

Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition.

Westra ER, Semenova E, Datsenko KA, Jackson RN, Wiedenheft B, Severinov K, Brouns SJ.

PLoS Genet. 2013;9(9):e1003742. doi: 10.1371/journal.pgen.1003742. Epub 2013 Sep 5.

18.

Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system.

Datsenko KA, Pougach K, Tikhonov A, Wanner BL, Severinov K, Semenova E.

Nat Commun. 2012 Jul 10;3:945. doi: 10.1038/ncomms1937.

PMID:
22781758
19.

Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence.

Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, van der Oost J, Brouns SJ, Severinov K.

Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10098-103. doi: 10.1073/pnas.1104144108. Epub 2011 Jun 6.

20.

Characterization of peptide chain length and constituency requirements for YejABEF-mediated uptake of microcin C analogues.

Vondenhoff GH, Blanchaert B, Geboers S, Kazakov T, Datsenko KA, Wanner BL, Rozenski J, Severinov K, Van Aerschot A.

J Bacteriol. 2011 Jul;193(14):3618-23. doi: 10.1128/JB.00172-11. Epub 2011 May 20.

21.

Transcription, processing and function of CRISPR cassettes in Escherichia coli.

Pougach K, Semenova E, Bogdanova E, Datsenko KA, Djordjevic M, Wanner BL, Severinov K.

Mol Microbiol. 2010 Sep;77(6):1367-79. doi: 10.1111/j.1365-2958.2010.07265.x.

22.
23.

Update on the Keio collection of Escherichia coli single-gene deletion mutants.

Yamamoto N, Nakahigashi K, Nakamichi T, Yoshino M, Takai Y, Touda Y, Furubayashi A, Kinjyo S, Dose H, Hasegawa M, Datsenko KA, Nakayashiki T, Tomita M, Wanner BL, Mori H.

Mol Syst Biol. 2009;5:335. doi: 10.1038/msb.2009.92. Epub 2009 Dec 22. No abstract available.

24.

Genome-wide screens: novel mechanisms in colicin import and cytotoxicity.

Sharma O, Datsenko KA, Ess SC, Zhalnina MV, Wanner BL, Cramer WA.

Mol Microbiol. 2009 Aug;73(4):571-85. doi: 10.1111/j.1365-2958.2009.06788.x. Epub 2009 Jul 22.

25.

eSGA: E. coli synthetic genetic array analysis.

Butland G, Babu M, Díaz-Mejía JJ, Bohdana F, Phanse S, Gold B, Yang W, Li J, Gagarinova AG, Pogoutse O, Mori H, Wanner BL, Lo H, Wasniewski J, Christopolous C, Ali M, Venn P, Safavi-Naini A, Sourour N, Caron S, Choi JY, Laigle L, Nazarians-Armavil A, Deshpande A, Joe S, Datsenko KA, Yamamoto N, Andrews BJ, Boone C, Ding H, Sheikh B, Moreno-Hagelseib G, Greenblatt JF, Emili A.

Nat Methods. 2008 Sep;5(9):789-95. doi: 10.1038/nmeth.1239.

PMID:
18677321
26.

Escherichia coli peptidase A, B, or N can process translation inhibitor microcin C.

Kazakov T, Vondenhoff GH, Datsenko KA, Novikova M, Metlitskaya A, Wanner BL, Severinov K.

J Bacteriol. 2008 Apr;190(7):2607-10. doi: 10.1128/JB.01956-07. Epub 2008 Jan 25.

27.

Structure of the complex of the colicin E2 R-domain and its BtuB receptor. The outer membrane colicin translocon.

Sharma O, Yamashita E, Zhalnina MV, Zakharov SD, Datsenko KA, Wanner BL, Cramer WA.

J Biol Chem. 2007 Aug 10;282(32):23163-70. Epub 2007 Jun 4.

28.

Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection.

Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H.

Mol Syst Biol. 2006;2:2006.0008. Epub 2006 Feb 21.

29.

Functional genomics by NMR spectroscopy. Phenylacetate catabolism in Escherichia coli.

Ismail W, El-Said Mohamed M, Wanner BL, Datsenko KA, Eisenreich W, Rohdich F, Bacher A, Fuchs G.

Eur J Biochem. 2003 Jul;270(14):3047-54.

30.

[Properties of mutants of bacteria belonging to the genus Erwinia devoid of common components of the phosphoenolpyruvate-dependent phosphotransferase system].

Datsenko KA, Evtushenko AN, Sergeev KV, Dobrynina OIu, Bol'shakova TN.

Genetika. 2002 Jul;38(7):904-10. Russian.

PMID:
12174582
31.
32.

Homogeneous expression of the P(BAD) promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter.

Khlebnikov A, Datsenko KA, Skaug T, Wanner BL, Keasling JD.

Microbiology. 2001 Dec;147(Pt 12):3241-7.

PMID:
11739756
33.

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Datsenko KA, Wanner BL.

Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5.

Supplemental Content

Loading ...
Support Center